| Name | Title | Contact Details |
|---|
ForeSee Health is a Chesterfield, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
When Ginger co-founder and COO, Karan Singh, was young, his mother would brew him ginger tea when she could sense that he was about to get sick. A preventative health remedy that originates from Southeast Asia, the ginger root is commonly used at the first sign of illness, before things get worse. Similar to this approach, the Ginger system takes a preventative approach to mental health, addressing issues before they evolve into greater challenges and providing support anywhere, at any time. By bringing the power of on-demand mental health support to hundreds of thousands of people globally, we continue to advance our mission of creating a world where mental health is never an obstacle.
Palo Pinto General Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Palo Pinto General Hospital is based in Mineral Wells, TX. You can find more information on Palo Pinto General Hospital at www.ppgh.com
Centerstone is a not-for-profit health system providing mental health and substance use disorder treatments. Services are available nationally through the operation of outpatient clinics, residential programs, the use of telehealth and an inpatient hospital. Centerstone also features specialized programs for the military community, therapeutic foster care, children`s services and employee assistance programs. Centerstone`s Research Institute provides guidance through research and technology, leveraging the best practices for use in all our communities. Centerstone`s Foundation secures philanthropic resources to support the work and mission of delivering care that changes people`s lives.
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.